20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-16
DOI
10.1111/cas.13881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression
- (2018) Zhiyun Yu et al. CANCER LETTERS
- FM19G11 inhibits O6 -methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions
- (2018) Chao-guo You et al. Cancer Medicine
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling
- (2017) Peng Han et al. Molecular Cancer
- Tanshinone IIA induces apoptosis via inhibition of Wnt/β-catenin/MGMT signaling in AtT-20 cells
- (2017) Zong-Yang Li et al. Molecular Medicine Reports
- Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
- (2017) R. H. Dahlrot et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT
- (2016) Chao Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway
- (2016) Z-M Zhang et al. ONCOGENE
- Glioma Stem Cells: Signaling, Microenvironment, and Therapy
- (2016) Brandon D. Liebelt et al. Stem Cells International
- Wnt Signaling in Cancer Stem Cell Biology
- (2016) Felipe de Sousa e Melo et al. Cancers
- Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers
- (2015) Qian Zhao et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
- (2015) FENGMING LAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
- (2015) Malin Wickström et al. Nature Communications
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Stereoselective Skin Anti-photoaging Properties of Ginsenoside Rg3 in UV-B-Irradiated Keratinocytes
- (2014) Chang-Jin Lim et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell
- (2014) Eun-Hwa Park et al. Journal of Ginseng Research
- Stereoisomers ginsenosides-20(S)-Rg3 and -20(R)-Rg3 differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma
- (2012) Hoi-Hin Kwok et al. BIOCHEMICAL PHARMACOLOGY
- Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: A 26-week intramuscular repeated administration study in rats
- (2012) J.-P. Liu et al. FOOD AND CHEMICAL TOXICOLOGY
- Sensitization of TRAIL-Induced Cell Death by 20(S)-Ginsenoside Rg3 via CHOP-Mediated DR5 Upregulation in Human Hepatocellular Carcinoma Cells
- (2012) J.-Y. Lee et al. MOLECULAR CANCER THERAPEUTICS
- STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
- (2012) Shinji Kohsaka et al. MOLECULAR CANCER THERAPEUTICS
- Towards personalized therapy for patients with glioblastoma
- (2011) Katsuyuki Shirai et al. Expert Review of Anticancer Therapy
- Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: A 26-week intramuscular repeated administration study in Beagle dogs
- (2011) J.-P. Liu et al. FOOD AND CHEMICAL TOXICOLOGY
- Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
- (2011) Kimberly Ng et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of Panax ginseng on Tumor Necrosis Factor-α-Mediated Inflammation: A Mini-Review
- (2011) Davy CW Lee et al. MOLECULES
- O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
- (2011) S. Spiegl-Kreinecker et al. NEURO-ONCOLOGY
- Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
- (2010) K A van Nifterik et al. BRITISH JOURNAL OF CANCER
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Sensitivity to temozolomide in brain tumor initiating cells
- (2010) M. D. Blough et al. NEURO-ONCOLOGY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
- (2009) Lee Jia et al. CURRENT MEDICINAL CHEMISTRY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
- (2009) M Flahaut et al. ONCOGENE
- 20(S)-Ginsenoside Rg3 Enhances Glucose-Stimulated Insulin Secretion and Activates AMPK
- (2008) Min Woo Park et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
- (2008) Gaspar J. Kitange et al. NEURO-ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now